Technology & Artificial Intelligence
%
Portfolio allocation to AI platforms *
* Based on current technology investment portfolio as of latest reporting period.
Investing in transformative platforms such as AI, machine learning, and advanced computing that drive the next era of innovation.
We target companies at the forefront of artificial intelligence, machine learning algorithms, and advanced computing infrastructure. Our investments focus on platforms that are reshaping industries from autonomous vehicles to healthcare diagnostics, positioning our portfolio for explosive growth in the AI-driven economy.
Robotics & Automation
B
Market value of robotics investments *
* Add some necessary disclaimer text to the performance metric here.
Backing cutting-edge solutions in robotics and smart systems that revolutionize how industries and consumers interact with technology.
From industrial automation and manufacturing robotics to consumer-facing smart systems, we invest in companies that are transforming traditional processes. Our portfolio includes breakthrough technologies in autonomous systems, precision robotics, and intelligent automation that are reshaping entire industries.
Life Sciences & Gene Therapy
%
Success rate of gene therapy trials *
* Add some necessary disclaimer text to the performance metric here.
Supporting breakthroughs in genetics, precision medicine, and gene therapy that have the potential to redefine healthcare.
We invest in pioneering companies developing revolutionary gene therapies, CRISPR technologies, and precision medicine platforms. Our portfolio focuses on treatments for rare diseases, cancer immunotherapies, and genetic disorders, supporting innovations that promise to transform patient outcomes and create substantial returns.
Biotechnology & Emerging Health Innovations
M
Average investment in biotech ventures *
* Add some necessary disclaimer text to the performance metric here.
Identifying and accelerating promising biotech ventures focused on next-generation treatments and therapies.
We partner with emerging biotech companies developing innovative therapies, diagnostic tools, and healthcare technologies. Our investments span regenerative medicine, personalized treatments, and breakthrough medical devices that address unmet medical needs and represent significant market opportunities.